Discover 1,416 paid clinical trials in Sarasota, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,416
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
for
Narcolepsy Type 2
Location: Brandon FL, Winter Park FL, Maimi FL, Macon GA,
Sponsor: Alkermes, Inc.
Sex: All
Age: 18 - 70
Code: NCT07502443
Phase 3, Recruiting
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
for
Liver Diseases, Alcoholic
Location: Brandon FL, Miami Lakes FL, Miami FL, Atlanta GA,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18 - 70
Code: NCT06613698
Phase 2, Recruiting
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
for
Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia
Location: Brandon FL, Winter Park FL, Miami FL, Macon GA,
Sponsor: Alkermes, Inc.
Sex: All
Age: 18 - 70
Code: NCT06767683
Phase 2, Phase 3, Recruiting
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Tampa FL, Safety Harbor FL, Clearwater FL,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06058377
Phase 3, Recruiting
A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
for
Metastatic Castration-Resistant Prostate Cancer
Location: Tampa FL, Miami FL, Chicago IL, Boston MA, Omaha NE
Sponsor: AstraZeneca
Sex: Male
Age: 18+
Code: NCT06879041
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
for
Relapsed/Refractory Multiple Myeloma
Location: Tampa FL, Miami FL, Jacksonville FL, Atlanta GA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT05850234
Phase 1, Phase 2, Recruiting
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
for
B-cell Acute Lymphoblastic Leukemia (B-ALL)
Location: Tampa FL, Atlanta GA, Richmond VA, Houston TX,
Sponsor: AstraZeneca
Sex: All
Age: 12+
Code: NCT06137118
Phase 1, Phase 2, Recruiting
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
for
Systemic Lupus Erythematosus
Location: Tampa FL, Clearwater FL, Plantation FL, Cooper City FL,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 12 - 70+
Code: NCT06133972
Phase 3, Recruiting
SAD and MAD of Inhaled AR-501 in Health Adults and P. Aeruginosa Infected Cystic Fibrosis Subjects
for
Cystic Fibrosis
Location: Tampa FL, Orlando FL, Gainesville FL, Hollywood FL,
Sponsor: Aridis Pharmaceuticals, Inc.
Sex: All
Age: 18 - 49
Code: NCT03669614
Phase 1, Phase 2, Recruiting
Study of AZD0754 in Participants With Metastatic Prostate Cancer
for
Metastatic Prostate Cancer
Location: Tampa FL, Atlanta GA, Houston TX, St Louis MO,
Sponsor: AstraZeneca
Sex: Male
Age: 18 - 70+
Code: NCT06267729
Phase 1, Phase 2, Recruiting
A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
for
Renal Insufficiency, Chronic
Location: Riverview FL, Savannah GA, Charlotte NC, Louisville KY,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT07624305
Phase 3, Recruiting
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
for
Weight Management
Location: Tampa FL, Dothan AL, Charleston SC, Woodstock GA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07667803
Phase 3, Recruiting
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
for
Acute Myeloid Leukemias
Location: Tampa FL, Greenville SC, Chapel Hill NC, Shreveport LA,
Sponsor: Syndax Pharmaceuticals
Sex: All
Age: 12+
Code: NCT07211958
Phase 3, Recruiting
Multi-Center, Prospective, Non-Interventional Study in Subjects With Limbal Stem Cell Deficiency
for
Limbal Stem Cell Deficiency
Location: Tampa FL, Smyrna TN, Norfolk VA, Louisville KY,
Sponsor: Claris Biotherapeutics, Inc.
Sex: All
Age: 12 - 70+
Code: NCT07636590
Recruiting
A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)